Terms: = Lymphoma AND TBL1XR1, C21, 79718, TBLR1, IRA1, FLJ12894, DC42
52 results:
1. The Genetic Profile of Large B-Cell lymphomas Presenting in the Ocular Adnexa.
Vest SD; Eriksen PRG; de Groot FA; de Groen RAL; Kleij AHR; Kirkegaard MK; Kamper P; Rasmussen PK; von Buchwald C; de Nully Brown P; Kiilgaard JF; Vermaat JSP; Heegaard S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542066
[TBL] [Abstract] [Full Text] [Related]
2. Socioeconomic status and adiposity in childhood cancer survivors: A cross-sectional retrospective study.
Štrublová L; Kepák T; Kuruczová D; Zlámal F; Holíková M; Kepáková K; Štěrba J; Bienertová-Vašků J
PLoS One; 2024; 19(2):e0298068. PubMed ID: 38363727
[TBL] [Abstract] [Full Text] [Related]
3. The genetic landscape of histologically transformed marginal zone lymphomas.
Li A; Yi H; Deng S; Ruan M; Xu P; Huo Y; Lu H; Shen X; Ouyang B; Cai M; Xu H; Wang Z; Zhang L; Zhu L; Peng Q; Gu Y; Xie J; Wang Y; Dong L; Liu Z; Wang C
Cancer; 2024 Apr; 130(8):1246-1256. PubMed ID: 37941429
[TBL] [Abstract] [Full Text] [Related]
4. Exploring
Mansoor A; Akhter A; Hamidi M; Roshan TM; Shabani-Rad MT; Stewart D
Anticancer Res; 2023 Nov; 43(11):4801-4807. PubMed ID: 37909960
[TBL] [Abstract] [Full Text] [Related]
5. Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL).
Kim PM; Nejati R; Lu P; Thakkar D; Mackrides N; Dupoux V; Nakhoda S; Baldwin DA; Pei J; Dave SS; Wang YL; Wasik MA
Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37730436
[TBL] [Abstract] [Full Text] [Related]
6. TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence.
Wu G; Yoshida N; Liu J; Zhang X; Xiong Y; Heavican-Foral TB; Mandato E; Liu H; Nelson GM; Yang L; Chen R; Donovan KA; Jones MK; Roshal M; Zhang Y; Xu R; Nirmal AJ; Jain S; Leahy C; Jones KL; Stevenson KE; Galasso N; Ganesan N; Chang T; Wu WC; Louissaint A; Debaize L; Yoon H; Dal Cin P; Chan WC; Ho Sui SJ; Ng SY; Feldman AL; Horwitz SM; Adelman K; Fischer ES; Chen CW; Weinstock DM; Brown M
Sci Transl Med; 2023 Sep; 15(714):eadi7244. PubMed ID: 37729434
[TBL] [Abstract] [Full Text] [Related]
7. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
[TBL] [Abstract] [Full Text] [Related]
8. Large B-cell lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell.
Los-de Vries GT; Stathi P; Rutkens R; Hijmering NJ; Luijks JACW; Groenen PJTA; de Jong D; Ylstra B; Roemer MGM
Cancer Res; 2023 Jun; 83(11):1917-1927. PubMed ID: 36971477
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic analysis of smoldering ATLL with skin eruptions based on genomic aberrations.
Mochida K; Nakahata S; Suzuki Y; Inoue K; Moriguchi S; Yamashita A; Amano M; Morishita K
J Dermatol Sci; 2023 Feb; 109(2):80-88. PubMed ID: 36842846
[TBL] [Abstract] [Full Text] [Related]
10. In Vitro Study of Cytotoxic Mechanisms of Alkylphospholipids and Alkyltriazoles in Acute Lymphoblastic Leukemia Models.
Jesus LOP; de Souza AA; Torquato HFV; Gontijo VS; Pereira de Freitas R; Gesteira TF; Coulson-Thomas VJ; Torquato RJS; Tanaka AS; Paredes-Gamero EJ; Judice WAS
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500726
[TBL] [Abstract] [Full Text] [Related]
11. Targeted sequencing reveals the relationship between mutations and patients' clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma.
Ma G; Gao Y; Jing X; He C; Liu H; Wu X; Gao Z; Li Y; Zhang S; Zhao G
Leuk Lymphoma; 2023 Jan; 64(1):140-150. PubMed ID: 36215154
[TBL] [Abstract] [Full Text] [Related]
12. TBL1X: At the crossroads of transcriptional and posttranscriptional regulation.
Pray BA; Youssef Y; Alinari L
Exp Hematol; 2022 Dec; 116():18-25. PubMed ID: 36206873
[TBL] [Abstract] [Full Text] [Related]
13. Targeted Treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic Leukemia.
Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
[TBL] [Abstract] [Full Text] [Related]
14. The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications.
Giannuzzi D; Marconato L; Fanelli A; Licenziato L; De Maria R; Rinaldi A; Rotta L; Rouquet N; Birolo G; Fariselli P; Mensah AA; Bertoni F; Aresu L
Lab Anim (NY); 2022 Jul; 51(7):191-202. PubMed ID: 35726023
[TBL] [Abstract] [Full Text] [Related]
15. The Genetic Landscape of Ocular Adnexa MALT lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.
Magistri M; Happ LE; Ramdial J; Lu X; Stathias V; Kunkalla K; Agarwal N; Jiang X; Schürer SC; Dubovy SR; Chapman JR; Vega F; Dave S; Lossos IS
Cancer Res Commun; 2021 Oct; 1(1):1-16. PubMed ID: 35528192
[TBL] [Abstract] [Full Text] [Related]
16. Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell lymphoma.
Zhu Y; Fu D; Shi Q; Shi Z; Dong L; Yi H; Liu Z; Feng Y; Liu Q; Fang H; Cheng S; Wang L; Tian Q; Xu P; Zhao W
Front Immunol; 2022; 13():842439. PubMed ID: 35401516
[TBL] [Abstract] [Full Text] [Related]
17. Resistance of B-Cell lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation.
Laurent C; Syrykh C; Hamon M; Adélaïde J; Guille A; Escudié F; Jalowicki G; Fina F; Bardet A; Mescam L; Molina TJ; Dartigues P; Parrens M; Sujobert P; Besson C; Birnbaum D; Xerri L
Am J Surg Pathol; 2022 Jun; 46(6):742-753. PubMed ID: 34799485
[TBL] [Abstract] [Full Text] [Related]
18. Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial.
Balasubramanian S; Hodkinson B; Schuster SJ; Fowler NH; Trotman J; Hess G; Cheson BD; Schaffer M; Sun S; Deshpande S; Vermeulen J; Salles G; Gopal AK
Cancer Med; 2022 Jan; 11(1):61-73. PubMed ID: 34791836
[TBL] [Abstract] [Full Text] [Related]
19. Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin.
Vela V; Juskevicius D; Dirnhofer S; Menter T; Tzankov A
Virchows Arch; 2022 Feb; 480(2):403-413. PubMed ID: 34494161
[TBL] [Abstract] [Full Text] [Related]
20. The molecular hallmarks of primary and secondary vitreoretinal lymphoma.
Bonzheim I; Sander P; Salmerón-Villalobos J; Süsskind D; Szurman P; Gekeler F; Spitzer MS; Steinhilber J; Kohler E; Büssgen M; Schittenhelm J; Salaverria I; Campo E; Coupland SE; Quintanilla-Martinez L; Fend F
Blood Adv; 2022 Mar; 6(5):1598-1607. PubMed ID: 34448823
[TBL] [Abstract] [Full Text] [Related]
[Next]
